We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
Cap. Flow
-$715M
Cap. Flow %
-2.15%
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$29M
2
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$14M
3
MSFT icon
Microsoft
MSFT
+$10.8M
4
META icon
Meta Platforms (Facebook)
META
+$10.5M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$6.72M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$34.4M
2
FRX
FOREST LABORATORIES INC
FRX
+$32.2M
3
XOM icon
ExxonMobil
XOM
+$23.9M
4
WBD icon
Warner Bros
WBD
+$15.4M
5
RTX icon
RTX Corp
RTX
+$13.7M

Sector Composition

Rank Sector Weight
1 Technology 14.81%
2 Financials 14.8%
3 Healthcare 13.73%
4 Industrials 10.72%
5 Energy 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
2826
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$161K ﹤0.01%
11,730
– –
MODN
2827
DELISTED
MODEL N, INC.
MODN
$161K ﹤0.01%
16,313
– –
SQBG
2828
DELISTED
Sequential Brands Group, Inc.
SQBG
$161K ﹤0.01%
323
– –
TSYS
2829
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
$161K ﹤0.01%
57,527
+4,850
+9% +$15K
DRTX
2830
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$161K ﹤0.01%
12,695
– –
BEAT
2831
DELISTED
BioTelemetry, Inc.
BEAT
$161K ﹤0.01%
23,990
– –
KVHI icon
2832
KVH Industries
KVHI
$184M
$160K ﹤0.01%
14,158
– –
CDMO
2833
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$160K ﹤0.01%
16,814
+1,700
+11% +$19K
NAVB
2834
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$159K ﹤0.01%
6,004
– –
STRL icon
2835
Sterling Infrastructure
STRL
$16.8B
$158K ﹤0.01%
20,554
– –
TTGT icon
2836
TechTarget
TTGT
$308M
$158K ﹤0.01%
18,427
– –
DGICA icon
2837
Donegal Group Class A
DGICA
$721M
$157K ﹤0.01%
10,190
– –
SNOW
2838
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
$157K ﹤0.01%
16,239
– –
PZN
2839
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$156K ﹤0.01%
16,346
– –
CYTR
2840
DELISTED
CytRx Corp
CYTR
$156K ﹤0.01%
10,209
– –
TVTX icon
2841
Travere Therapeutics
TVTX
$5.1B
$155K ﹤0.01%
17,138
– –
OCLR
2842
DELISTED
Oclaro Inc.
OCLR
$155K ﹤0.01%
108,264
– –
CALL
2843
DELISTED
magicJack VocalTec Ltd
CALL
$155K ﹤0.01%
15,701
-400
-2% -$5.06K
BONT
2844
DELISTED
Bon-Ton Stores Inc/The
BONT
$155K ﹤0.01%
18,533
-100
-0.5% -$962
JGW
2845
DELISTED
J G WENTWORTH CO CL A COM STK (DE)
JGW
$155K ﹤0.01%
12,510
– –
MTEM
2846
DELISTED
Molecular Templates, Inc.
MTEM
$154K ﹤0.01%
259
– –
MILL
2847
DELISTED
MILLER ENERGY RESOURCES, INC COM STK
MILL
$154K ﹤0.01%
35,011
+275
+0.8% +$1.38K
MDGL icon
2848
Madrigal Pharmaceuticals
MDGL
$11.6B
$153K ﹤0.01%
1,450
+8
+0.6% +$1.11K
IHC
2849
DELISTED
Independence Holding Company
IHC
$153K ﹤0.01%
11,489
– –
CPSS icon
2850
Consumer Portfolio Services
CPSS
$208M
$152K ﹤0.01%
23,643
– –
112 113
114
115 116

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RhumbLine Advisers's Q3 2014 Portfolio in Review

As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
  • RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
  • RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
  • RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
  • RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
  • RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.